Brussels, 28/03/2011 (Agence Europe) - On Monday 28 March, the European Commission launched a public consultation with a view to modernising transparency rules on national procedures for pricing and reimbursement of medicines. Directive 89/105/EEC, often referred to as the transparency directive has not been amended since 1989 despite substantial changes in the pharmaceutical market. Although the prices of medicines and reimbursement are decided at national level, the transparency directive...